| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 53,972 | 30,629 | 26,762 | 28,849 |
| Short-term investments | 216,957 | 114,108 | 147,375 | 162,729 |
| Accounts receivable, net (allowance for doubtful accounts was 375 for each period) | 58 | 6 | 179 | 225 |
| Prepaid expenses and other current assets | 4,365 | 3,646 | 4,184 | 4,155 |
| Total current assets | 275,352 | 148,389 | 178,500 | 195,958 |
| Property and equipment, gross | 99,811 | 82,801 | 69,546 | NaN |
| Less accumulated depreciation | 7,328 | 6,204 | 5,195 | NaN |
| Property and equipment, net | 92,483 | 76,597 | 64,351 | 62,599 |
| Right-of-use asset, net | 2,444 | 1,500 | 1,536 | 1,767 |
| Restricted cash | NaN | NaN | NaN | 0 |
| Intangible assets, in-process research and development | 40,000 | 40,000 | 50,000 | 50,000 |
| Other assets, net | 490 | 486 | 438 | 401 |
| Total assets | 410,769 | 266,972 | 294,825 | 310,725 |
| Deferred income (note 3) | NaN | 0 | 0 | 0 |
| Accounts payable and accrued expenses | 26,485 | 20,511 | 13,148 | 7,048 |
| Lease liability | 1,069 | 623 | 704 | 847 |
| Accrued personnel expenses | 3,876 | 7,489 | 6,711 | 5,037 |
| Note payable | 56 | 56 | 55 | 54 |
| Total current liabilities | 31,486 | 28,679 | 20,618 | 12,986 |
| Lease liability, net of current portion | 1,552 | 1,005 | 971 | 1,071 |
| Note payable, net of current portion | 1,554 | 1,569 | 1,583 | 1,597 |
| Deferred income (note 3) | 26,600 | 26,600 | 26,600 | 26,600 |
| Deferred tax liability | 1,702 | 1,702 | 2,495 | 2,495 |
| Other noncurrent liabilities | 437 | 386 | 342 | 284 |
| Total liabilities | 63,331 | 59,941 | 52,609 | 45,033 |
| Common stock 0.001 par value 750,000,000 shares authorized 114,017,755 and 74,337,990 shares issued | 114 | 74 | 74 | 74 |
| Additional paid-in capital | 708,579 | 541,687 | 539,378 | 536,996 |
| Accumulated other comprehensive (loss) income | -226 | 110 | 114 | 3 |
| Accumulated deficit | -361,029 | -334,840 | -297,350 | -271,381 |
| Total stockholders' equity | 347,438 | 207,031 | 242,216 | 265,692 |
| Total liabilities and stockholders' equity | 410,769 | 266,972 | 294,825 | 310,725 |
Perspective Therapeutics, Inc. (CATX)
Perspective Therapeutics, Inc. (CATX)